Skip to content

Clinical trials

Phase 2 COVID-19 trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2 Country / region: Belgium Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20209
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Ghent2
Aquilon Pharmaceuticals S.A.1
Atea Pharmaceuticals, Inc.1
Basilea Pharmaceutica1
GlaxoSmithKline1
Grand Medical Pty Ltd.1
Inotrem1
NEURALIS s.a.1
Novartis Pharmaceuticals1
PharmaMar1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1913
Severe Acute Respiratory Syndrome3
Coronavirus Infections2
Acute Lung Injury1
Anemia, Sickle Cell1
Aspergillosis1
Hypoxia1
Invasive Fungal Infections1
Mycoses1
Pulmonary Aspergillosis1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.